Aviva PLC Veracyte, Inc. Transaction History

Aviva PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 10, 2021	SELL	$32.94 - $56.62 $814,803 - $1.4 Million	-24,736 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$44.47 - $81.38 $674,120 - $1.23 Million	-15,159 Reduced 38.0%	24,736 $1.33 Million
Q4 2020 Feb 10, 2021	SELL	$32.49 - $61.88 $1.05 Million - $2 Million	-32,340 Reduced 44.77%	39,895 $1.95 Million
Q3 2020 Nov 12, 2020	SELL	$26.73 - $35.67 $565,981 - $755,276	-21,174 Reduced 22.67%	72,235 $2.35 Million
Q2 2020 Aug 13, 2020	SELL	$19.49 - $28.11 $1.3 Million - $1.88 Million	-66,746 Reduced 41.68%	93,409 $2.42 Million
Q1 2020 May 14, 2020	BUY	$16.13 - $30.17 $2.58 Million - $4.83 Million	160,155 New	160,155 $3.89 Million

307

81.6M

134K

13.3K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.97B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

Stay updated on Aviva PLC with notifications on news.